Anal Carcinoma, version 2.2018 clinical practice guidelines in Oncology

Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, Lynette Cederquist, Yi Jen Chen, Kristen K. Ciombor, Stacey Cohen, Harry S. Cooper, Dustin Deming, Paul F. Engstrom, Jean L. Grem, Axel Grothey, Howard S. Hochster, Sarah Hoffe, Steven Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey MeyerhardtMary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky-Himelfarb, Christopher G. Willett, Evan Wuthrick, Kristina M. Gregory, Deborah A. Freedman-Cass

Research output: Contribution to journalReview articlepeer-review

373 Scopus citations

Abstract

The NCCN Guidelines for Anal Carcinoma provide recommendations for the management of patients with squamous cell carcinoma of the anal canal or perianal region. Primary treatment of anal cancer usually includes chemoradiation, although certain lesions can be treated with margin-negative local excision alone. Disease surveillance is recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is essential for optimal patient care.

Original languageEnglish (US)
Pages (from-to)852-871
Number of pages20
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume16
Issue number7
DOIs
StatePublished - Jul 1 2018

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Anal Carcinoma, version 2.2018 clinical practice guidelines in Oncology'. Together they form a unique fingerprint.

Cite this